GILDTICKER
Gilead Sciences, Inc.
Congress has disclosed 54 buys and 37 sells of GILD (Gilead Sciences, Inc.) in official financial disclosures, each linked to its original filing. A transparency record — not investment advice.
Activity Congressional Activity
54
Buy
37
Sell
+17
Net
31
Active politicians
Round-trip watch Still on the books
Members who disclosed buying GILD and have not disclosed selling, versus their own entry (the most recent disclosed buy). "Open" means no disclosed sale — never "still holds" — and the % is unrealised, on paper. Not investment advice.
| Member | Entry (last buy) | Entry price | Now | vs entry | Status |
|---|---|---|---|---|---|
| Rohit Khanna | 2024-11-15 | $83.77 | $170.68 | +103.7% | in profit |
| Marjorie Taylor Greene | 2025-06-06 | $108.22 | $170.68 | +57.7% | in profit |
| Alan Armstrong | 2026-03-27 | $132.63 | $170.68 | +28.7% | in profit |
| Jared Moskowitz | 2026-05-06 | $134.65 | $170.68 | +26.8% | in profit |
Price as of 2026-10-30. Counted open while disclosed buys outnumber disclosed sells; tracks the price, not exact position size (amounts are ranges).
Price & congressional trades
Buy
Sell
Fundamentals · FY2026 Valuation
Standard valuation multiples from SEC-reported GAAP financials (trailing twelve months), each compared to the median for Health. We use reported GAAP, not forward or adjusted earnings, so our figures can sit higher than sites that do — especially for companies with falling profit. Relative context — not a target price or investment advice.
P/B
16.23
▲ pricier than
Health (median 4.4)
how it's calculated
P/B = price ÷ book value per share
$170.68 ÷ $10.51 = 16.23
Based on GAAP trailing-twelve-month financials (SEC filings) and the latest close. Other sites may show a different multiple when they use forward (projected) or non-GAAP adjusted figures instead of reported GAAP — for a company with volatile profit those can differ in either direction from the GAAP figure shown here.
Legislation Related Legislation
Recent bills in this stock's sector (Health). Sector-level context from Congress.gov — a bill names a policy area, not this company specifically.
| Bill | Title | Policy area | Latest action |
|---|---|---|---|
| HR 10887 | Protecting Consumer Access to Generic Drugs Act of 2026 | Health | 2026-10-22 |
| HR 10874 | Medicare Low Income Subsidy Equality Act of 2026 | Health | 2026-10-22 |
| HR 10858 | CARE for Blood Cancer Act of 2026 | Health | 2026-10-22 |
| HR 10810 | National Patient Safety Board Act of 2026 | Health | 2026-10-15 |
| HR 10824 | Stroke Education and EMS Care Improvement Act of 2026 | Health | 2026-10-15 |
92 trades Recent Congressional Trades
Two things to watch per trade: the disclosure lag (how many days passed before the trade was made public) and the price move in that window (how the stock moved during those non-public days). A sell followed by a price drop, or a buy followed by a rise, means well-timed trading — visible here in the open. Note: the Score measures how notable a trade is, not whether it made money — the price move is shown for context and isn't part of it.
| Politician | Chamber | Type | Owner | Date | Disclosure lag | Price move in that window | Amount | Score | Source |
|---|---|---|---|---|---|---|---|---|---|
| Rohit Khanna | House | SELL OCR ◆ insider convergence | Child | 2026-08-10 | 22 days | +12.7% | $1K–$15K | 33.8 | ↗ filing |
| Jared Moskowitz | House | BUY ◆ insider divergence | Child · Morgan Stanley Active Assets (5) | 2026-05-06 | 25 days | -1.4% | $1K–$15K 0.3% of NW |
66.1 | ↗ filing |
| Jared Moskowitz | House | BUY ◆ insider divergence | Self · Morgan Stanley Active Assets (1) | 2026-05-06 | 25 days | -1.4% | $1K–$15K 0.3% of NW |
66.1 | ↗ filing |
| Alan Armstrong | Senate | BUY ◆ insider divergence | Self | 2026-03-27 | 116 days | -2.3% | $1K–$15K | 99.1 | ↗ eFD |
| Josh Gottheimer | House | BUY ◆ insider divergence | Joint · Morgan Stanley - Select UMA Account # 1 | 2026-01-27 | 7 days | +1.6% | $1K–$15K <0.1% of NW |
5.1 | ↗ filing |
| Valerie Hoyle | House | SELL ◆ insider convergence | Spouse · Fidelity Rollover IRA | 2025-09-23 | 0 days | 0.0% | $1K–$15K 0.8% of NW |
30.3 | ↗ filing |
| Marjorie Taylor Greene | House | BUY ◆ insider divergence | Self | 2025-06-06 | 3 days | +0.5% | $1K–$15K | 11.5 | ↗ filing |
| Josh Gottheimer | House | SELL ◆ insider convergence | Joint · Morgan Stanley - Select UMA Account # 1 | 2025-05-14 | 21 days | +10.8% | $1K–$15K <0.1% of NW |
7.4 | ↗ filing |
| Marjorie Taylor Greene | House | BUY ◆ insider divergence | Self · Marjorie IRA | 2025-05-05 | 1 days | -4.8% | $1K–$15K | 22.3 | ↗ filing |
| Marjorie Taylor Greene | House | BUY ◆ insider divergence | Self | 2025-05-05 | 1 days | -4.8% | $1K–$15K | 22.3 | ↗ filing |
| Carol Devine Miller | House | BUY ◆ insider convergence | Self · Matt Miller Investment Management Account | 2025-03-10 | 32 days | -11.0% | $1K–$15K <0.1% of NW |
89.3 | ↗ filing |
| Josh Gottheimer | House | BUY ◆ insider convergence | Joint · Morgan Stanley - Select UMA Account # 1 | 2025-03-07 | 28 days | -8.0% | $1K–$15K <0.1% of NW |
20.0 | ↗ filing |
| Marjorie Taylor Greene | House | BUY ◆ insider convergence | Self | 2024-12-24 | 2 days | +0.5% | $1K–$15K | 40.4 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider convergence | Child | 2024-11-15 | 19 days | +3.6% | $1K–$15K | 18.1 | ↗ filing |
| Valerie Hoyle | House | BUY ◆ insider convergence | Spouse · Fidelity Rollover IRA | 2024-10-29 | 317 days | +36.8% | $1K–$15K 0.8% of NW |
69.5 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider convergence | Child | 2024-05-29 | 6 days | — | $1K–$15K | 19.6 | ↗ filing |
| Thomas Tuberville | Senate | BUY PUT ◆ insider convergence | Joint | 2024-05-10 | 817 days | — | $1K–$15K | 96.2 | ↗ eFD |
| Thomas Tuberville | Senate | OTHER | Joint | 2024-05-08 | 819 days | — | $1K–$15K | 98.8 | ↗ eFD |
| Rohit Khanna | House | BUY OCR ◆ insider convergence | Child | 2024-03-25 | 9 days | — | $1K–$15K | 15.7 | ↗ filing |
| Rohit Khanna | House | SELL OCR ◆ insider divergence | Child | 2024-02-13 | 21 days | — | $1K–$15K | 22.3 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider convergence | Child | 2023-12-05 | 30 days | — | $1K–$15K | 40.4 | ↗ filing |
| Rohit Khanna | House | BUY OCR ◆ insider divergence | Child | 2023-11-03 | 32 days | — | $1K–$15K | 75.9 | ↗ filing |
| Greg Stanton | House | SELL ◆ insider convergence | Spouse | 2023-10-24 | 2 days | — | $1K–$15K 0.5% of NW |
40.4 | ↗ filing |
| Greg Stanton | House | BUY ◆ insider divergence | Spouse | 2023-09-26 | 25 days | — | $1K–$15K 0.5% of NW |
75.9 | ↗ filing |
| Daniel Goldman | House | SELL ◆ insider divergence | Self · Daniel Goldman Grandchildren 1986 Trust > TACS R3K | 2023-07-12 | 27 days | — | $15K–$50K <0.1% of NW |
56.6 | ↗ filing |
| Zoe Lofgren | House | SELL ◆ insider divergence | Spouse · John Marshall Collins Rollover IRA | 2023-05-25 | 12 days | — | $1K–$15K 0.1% of NW |
40.4 | ↗ filing |
| Daniel Goldman | House | BUY ◆ insider divergence | Self · Daniel Goldman Grandchildren 1986 Trust > TACS R3K | 2023-03-06 | 28 days | — | $15K–$50K <0.1% of NW |
90.9 | ↗ filing |
| Zoe Lofgren | House | BUY | Spouse · John Marshall Collins Rollover IRA | 2022-09-09 | 32 days | — | $1K–$15K 0.1% of NW |
75.9 | ↗ filing |
| Carol Devine Miller | House | SELL | Spouse | 2021-11-10 | 21 days | — | $15K–$50K 0.1% of NW |
99.5 | ↗ filing |
| Marjorie Taylor Greene | House | BUY | Joint | 2021-01-21 | 0 days | — | $1K–$15K | 75.9 | ↗ filing |
| Gilbert Cisneros | House | SELL | Self | 2020-12-22 | 17 days | — | $1K–$15K 0.1% of NW |
31.8 | ↗ filing |
| Dean Phillips | House | SELL | Self | 2020-12-18 | 20 days | — | $1K–$15K <0.1% of NW |
26.5 | ↗ filing |
| Dean Phillips | House | BUY | Self | 2020-09-23 | 14 days | — | $1K–$15K <0.1% of NW |
22.3 | ↗ filing |
| Ed Perlmutter | House | SELL | Spouse | 2020-09-01 | 40 days | — | $1K–$15K | 40.4 | ↗ filing |
| Ed Perlmutter | House | BUY | Spouse | 2020-07-15 | 57 days | — | $1K–$15K | 75.9 | ↗ filing |
| William Timmons | House | SELL | Spouse | 2020-06-29 | 0 days | — | $1K–$15K | 82.9 | ↗ filing |
| Roger Marshall | House | BUY | Child | 2020-05-07 | 0 days | — | $1K–$15K | 22.3 | ↗ filing |
| Roger Marshall | House | BUY | Child | 2020-05-05 | 0 days | — | $1K–$15K | 40.4 | ↗ filing |
| Roger Marshall | House | BUY | Child | 2020-05-04 | 0 days | — | $1K–$15K | 75.9 | ↗ filing |
| Gilbert Cisneros | House | BUY | Self | 2020-03-18 | 28 days | — | $1K–$15K 0.1% of NW |
40.4 | ↗ filing |
| Mikie Sherrill | House | SELL | Self | 2020-02-20 | 12 days | — | $1K–$15K 0.1% of NW |
15.7 | ↗ filing |
| Gilbert Cisneros | House | BUY | Self | 2020-02-07 | 32 days | — | $1K–$15K 0.1% of NW |
86.8 | ↗ filing |
| Mikie Sherrill | House | BUY | Self | 2020-01-21 | 17 days | — | $1K–$15K 0.1% of NW |
31.8 | ↗ filing |
| Mikie Sherrill | House | SELL | Self | 2019-12-18 | 16 days | — | $1K–$15K 0.1% of NW |
40.4 | ↗ filing |
| Earl Blumenauer | House | BUY | Spouse | 2019-10-25 | 19 days | — | $1K–$15K 0.1% of NW |
22.3 | ↗ filing |
| Bill Flores | House | BUY | Self | 2019-09-19 | 15 days | — | $1K–$15K | 6.8 | ↗ filing |
| Dean Phillips | House | SELL | Self | 2019-05-13 | 25 days | — | $1K–$15K <0.1% of NW |
59.5 | ↗ filing |
| Bill Flores | House | SELL | Self | 2019-05-08 | 28 days | — | $1K–$15K | 29.6 | ↗ filing |
| Mikie Sherrill | House | SELL | Self | 2019-04-18 | 14 days | — | $1K–$15K 0.1% of NW |
93.1 | ↗ filing |
| Bill Flores | House | BUY | Self | 2019-03-25 | 9 days | — | $1K–$15K | 10.6 | ↗ filing |
| Dean Phillips | House | SELL | Self | 2019-01-04 | 32 days | — | $1K–$15K <0.1% of NW |
75.9 | ↗ filing |
| John Yarmuth | House | SELL | Self | 2018-11-26 | 11 days | — | $1K–$15K | 75.9 | ↗ filing |
| Earl Blumenauer | House | BUY | Spouse | 2018-07-17 | 29 days | — | $1K–$15K 0.1% of NW |
40.4 | ↗ filing |
| Earl Blumenauer | House | BUY | Spouse | 2018-02-28 | 6 days | — | $1K–$15K 0.1% of NW |
75.9 | ↗ filing |
| John Rutherford | House | BUY | Self | 2017-07-17 | 14 days | — | $1K–$15K 0.8% of NW |
75.9 | ↗ filing |
| Josh Gottheimer | House | SELL | Joint | 2017-04-17 | 478 days | — | $1K–$15K <0.1% of NW |
40.4 | ↗ filing |
| Gary Palmer | House | BUY | Spouse | 2017-04-04 | 0 days | — | $1K–$15K 0.3% of NW |
98.8 | ↗ filing |
| Thomas Rooney | House | SELL | Self | 2017-03-06 | 26 days | — | $15K–$50K | 49.8 | ↗ filing |
| Josh Gottheimer | House | SELL | Joint | 2017-02-21 | 533 days | — | $1K–$15K <0.1% of NW |
86.8 | ↗ filing |
| Thomas Rooney | House | BUY | Self | 2016-12-12 | 27 days | — | $15K–$50K | 48.0 | ↗ filing |
| Richard Hanna | House | SELL | Self | 2016-11-17 | 48 days | — | $100K–$250K | 51.3 | ↗ filing |
| Richard Hanna | House | BUY | Self | 2016-09-09 | 17 days | — | $15K–$50K | 28.8 | ↗ filing |
| Bill Flores | House | SELL | Self | 2016-08-16 | 24 days | — | $1K–$15K | 33.6 | ↗ filing |
| Lamar Smith | House | SELL | Self | 2016-08-16 | 16 days | — | $1K–$15K | 25.7 | ↗ filing |
| Michael Conaway | House | SELL | Spouse | 2016-08-11 | 5 days | — | $1K–$15K | 93.1 | ↗ filing |
| Lamar Smith | House | SELL | Self | 2016-07-22 | 10 days | — | $1K–$15K | 28.4 | ↗ filing |
| Bill Flores | House | SELL | Self | 2016-06-10 | 25 days | — | $1K–$15K | 31.8 | ↗ filing |
| Raúl Grijalva | House | SELL | Spouse | 2016-05-20 | 20 days | — | $1K–$15K | 26.5 | ↗ filing |
| Bill Flores | House | SELL | Self | 2016-04-18 | 28 days | — | $1K–$15K | 40.4 | ↗ filing |
| Richard Hanna | House | BUY | Self | 2016-03-28 | 11 days | — | $100K–$250K | 58.3 | ↗ filing |
| Bill Flores | House | BUY | Self | 2016-02-17 | 16 days | — | $15K–$50K | 90.9 | ↗ filing |
| Scott Rigell | House | SELL | Spouse | 2016-01-12 | 19 days | — | $1K–$15K | 40.4 | ↗ filing |
| Thomas Rooney | House | BUY | Self | 2015-11-12 | 30 days | — | $1K–$15K | 40.4 | ↗ filing |
| Thomas Rooney | House | BUY | Self | 2015-10-15 | 31 days | — | $1K–$15K | 86.8 | ↗ filing |
| Ed Whitfield | House | BUY | Spouse | 2015-09-22 | 8 days | — | $1K–$15K | 31.8 | ↗ filing |
| Lamar Smith | House | SELL | Self | 2015-09-21 | 10 days | — | $1K–$15K | 8.6 | ↗ filing |
| Ed Whitfield | House | BUY | Spouse | 2015-08-06 | 25 days | — | $1K–$15K | 52.4 | ↗ filing |
| Ed Whitfield | House | BUY | Spouse | 2015-08-04 | 27 days | — | $1K–$15K | 86.8 | ↗ filing |
| Scott Rigell | House | BUY | Spouse | 2015-07-22 | 5 days | — | $1K–$15K | 86.8 | ↗ filing |
| Raúl Grijalva | House | SELL | Spouse | 2015-05-28 | 13 days | — | $1K–$15K | 22.3 | ↗ filing |
| John Boehner | House | BUY | Self | 2015-05-15 | 0 days | — | $15K–$50K | 94.9 | ↗ filing |
| Lamar Smith | House | BUY | Self | 2015-05-05 | 30 days | — | $1K–$15K | 19.6 | ↗ filing |
| Raúl Grijalva | House | BUY | Spouse | 2015-01-15 | 18 days | — | $1K–$15K | 40.4 | ↗ filing |
| Raúl Grijalva | House | BUY | Spouse | 2014-12-30 | 6 days | — | $1K–$15K | 75.9 | ↗ filing |
| Lamar Smith | House | SELL | Self | 2014-12-23 | 13 days | — | $1K–$15K | 15.7 | ↗ filing |
| Lamar Smith | House | SELL | Self | 2014-10-30 | 32 days | — | $1K–$15K | 22.3 | ↗ filing |
| Richard Hanna | House | SELL | Self | 2014-09-12 | 32 days | — | $1K–$15K | 22.3 | ↗ filing |
| David Price | House | BUY | Joint | 2014-08-12 | 6 days | — | $1K–$15K | 75.9 | ↗ filing |
| Lamar Smith | House | SELL | Self | 2014-08-12 | 21 days | — | $1K–$15K | 40.4 | ↗ filing |
| Richard Hanna | House | BUY | Self | 2014-03-26 | 13 days | — | $15K–$50K | 56.6 | ↗ filing |
| Richard Hanna | House | BUY | Self | 2014-02-21 | 14 days | — | $1K–$15K | 86.8 | ↗ filing |
| Lamar Smith | House | BUY | Self | 2014-02-06 | 26 days | — | $1K–$15K | 86.8 | ↗ filing |
Corporate insiders · SEC Form 4 Insider Activity
What the company's own officers and directors did in GILD — open-market purchases and sales from SEC Form 4 filings (option exercises, grants and tax withholding are excluded). This is context for the congressional activity above, never a buy/sell signal, and the two datasets are kept separate on purpose. Does convergence mean anything? →
13
Congress trades with insider convergence
13
…with insider divergence
159
Insider open-market trades
Of the congressional trades in GILD, 13 coincided with corporate insiders moving the same way within 60 days, and 13 with insiders moving the opposite way. This is co-occurrence only — whether it carries any edge is tested honestly on the convergence page.
| Date | Insider | Role | Type | Size | Source |
|---|---|---|---|---|---|
| 2026-11-02 | O'Day Daniel Patrick | C-suite | SELL 10b5-1 | $268K | ↗ EDGAR |
| 2026-11-02 | O'Day Daniel Patrick | C-suite | SELL 10b5-1 | $286K | ↗ EDGAR |
| 2026-11-02 | O'Day Daniel Patrick | C-suite | SELL 10b5-1 | $322K | ↗ EDGAR |
| 2026-11-02 | O'Day Daniel Patrick | C-suite | SELL 10b5-1 | $1.3M | ↗ EDGAR |
| 2026-11-02 | O'Day Daniel Patrick | C-suite | SELL 10b5-1 | $342K | ↗ EDGAR |
| 2026-10-30 | O'Day Daniel Patrick | C-suite | SELL 10b5-1 | $2.8M | ↗ EDGAR |
| 2026-10-15 | Dickinson Andrew D | C-suite | SELL 10b5-1 | $469K | ↗ EDGAR |
| 2026-10-15 | Mercier Johanna | C-suite | SELL 10b5-1 | $469K | ↗ EDGAR |
| 2026-10-01 | O'Day Daniel Patrick | C-suite | SELL 10b5-1 | $1.8M | ↗ EDGAR |
| 2026-10-01 | O'Day Daniel Patrick | C-suite | SELL 10b5-1 | $446K | ↗ EDGAR |
| 2026-09-15 | Dickinson Andrew D | C-suite | SELL 10b5-1 | $436K | ↗ EDGAR |
| 2026-09-15 | Mercier Johanna | C-suite | SELL 10b5-1 | $230K | ↗ EDGAR |
| 2026-09-15 | Mercier Johanna | C-suite | SELL 10b5-1 | $116K | ↗ EDGAR |
| 2026-09-15 | Mercier Johanna | C-suite | SELL 10b5-1 | $87K | ↗ EDGAR |
| 2026-09-01 | O'Day Daniel Patrick | C-suite | SELL 10b5-1 | $236K | ↗ EDGAR |
| 2026-09-01 | O'Day Daniel Patrick | C-suite | SELL 10b5-1 | $1.2M | ↗ EDGAR |
| 2026-09-01 | O'Day Daniel Patrick | C-suite | SELL 10b5-1 | $808K | ↗ EDGAR |
| 2026-08-26 | WELTERS ANTHONY | Director | SELL 10b5-1 | $462K | ↗ EDGAR |
| 2026-08-26 | WELTERS ANTHONY | Director | SELL 10b5-1 | $685K | ↗ EDGAR |
| 2026-08-26 | WELTERS ANTHONY | Director | SELL 10b5-1 | $504K | ↗ EDGAR |
| 2026-08-26 | WELTERS ANTHONY | Director | SELL 10b5-1 | $1.0M | ↗ EDGAR |
| 2026-08-20 | Bluestone Jeffrey | Director | SELL 10b5-1 | $167K | ↗ EDGAR |
| 2026-08-20 | Bluestone Jeffrey | Director | SELL 10b5-1 | $263K | ↗ EDGAR |
| 2026-08-20 | Bluestone Jeffrey | Director | SELL 10b5-1 | $242K | ↗ EDGAR |
| 2026-08-20 | Bluestone Jeffrey | Director | SELL 10b5-1 | $4K | ↗ EDGAR |
Combined timeline — Congress & insiders
Both sets of trades on one timeline, newest first, so you can see when they lined up. Congress vs ◆ insider.
| Date | Who | Type | Size | |
|---|---|---|---|---|
| ◆ insider | 2026-11-02 | O'Day Daniel Patrick C-suite 10b5-1 | SELL | $268K |
| ◆ insider | 2026-11-02 | O'Day Daniel Patrick C-suite 10b5-1 | SELL | $286K |
| ◆ insider | 2026-11-02 | O'Day Daniel Patrick C-suite 10b5-1 | SELL | $322K |
| ◆ insider | 2026-11-02 | O'Day Daniel Patrick C-suite 10b5-1 | SELL | $1.3M |
| ◆ insider | 2026-11-02 | O'Day Daniel Patrick C-suite 10b5-1 | SELL | $342K |
| ◆ insider | 2026-10-30 | O'Day Daniel Patrick C-suite 10b5-1 | SELL | $2.8M |
| ◆ insider | 2026-10-15 | Dickinson Andrew D C-suite 10b5-1 | SELL | $469K |
| ◆ insider | 2026-10-15 | Mercier Johanna C-suite 10b5-1 | SELL | $469K |
| ◆ insider | 2026-10-01 | O'Day Daniel Patrick C-suite 10b5-1 | SELL | $1.8M |
| ◆ insider | 2026-10-01 | O'Day Daniel Patrick C-suite 10b5-1 | SELL | $446K |
| ◆ insider | 2026-09-15 | Dickinson Andrew D C-suite 10b5-1 | SELL | $436K |
| ◆ insider | 2026-09-15 | Mercier Johanna C-suite 10b5-1 | SELL | $230K |
| ◆ insider | 2026-09-15 | Mercier Johanna C-suite 10b5-1 | SELL | $116K |
| ◆ insider | 2026-09-15 | Mercier Johanna C-suite 10b5-1 | SELL | $87K |
| ◆ insider | 2026-09-01 | O'Day Daniel Patrick C-suite 10b5-1 | SELL | $236K |
| ◆ insider | 2026-09-01 | O'Day Daniel Patrick C-suite 10b5-1 | SELL | $1.2M |
| ◆ insider | 2026-09-01 | O'Day Daniel Patrick C-suite 10b5-1 | SELL | $808K |
| ◆ insider | 2026-08-26 | WELTERS ANTHONY Director 10b5-1 | SELL | $462K |
| ◆ insider | 2026-08-26 | WELTERS ANTHONY Director 10b5-1 | SELL | $685K |
| ◆ insider | 2026-08-26 | WELTERS ANTHONY Director 10b5-1 | SELL | $504K |
| ◆ insider | 2026-08-26 | WELTERS ANTHONY Director 10b5-1 | SELL | $1.0M |
| ◆ insider | 2026-08-20 | Bluestone Jeffrey Director 10b5-1 | SELL | $167K |
| ◆ insider | 2026-08-20 | Bluestone Jeffrey Director 10b5-1 | SELL | $263K |
| ◆ insider | 2026-08-20 | Bluestone Jeffrey Director 10b5-1 | SELL | $242K |
FAQ Common questions
How much has Congress traded GILD?
54 disclosed buys and 37 sells of GILD (Gilead Sciences, Inc.) appear in official congressional financial disclosures.
Is it legal for members of Congress to trade GILD?
Members of Congress may trade stocks but must disclose it under the STOCK Act. QuantCapitol tracks those public disclosures for transparency — nothing here is an accusation of wrongdoing or investment advice.
Where does this data come from?
Official US House Clerk and Senate electronic financial disclosures. Every trade links back to its original filing so you can verify it yourself.